| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Cervarix | GSK Ltd. | 0.5 ml | 1 dose | KES 3,198 | |||
| Gardasil | MSD Ltd | 0.5 ml | 1 dose | KES 7,672 |
| Human Papillomavirus vaccine More info | |
|---|---|
| Mode Of Action | excite immune system to produce antibodies corresponding to the vaccine antigen |
| Drug Indication | Active immunization against Human Papillomavirus for: prevention of cervical cancer, condyloma acuminata (genital warts), cervical adenocarcinoma in situ, cervical intraepithelial neoplasia grade 2 & 3, vulvar intraepithelial neoplasia grade 2 & 3, vaginal intraepithelial neoplasia grade 2 & 3, and vulvar intraepithelial neoplasia grade 2 & 3 |
| Drug Category | DRUGS ACTING ON INFECTIONS |
| Drug Sub-Category | Vaccines |
| Dosage | 3 doses of 0.5 ml each IM 0, 1 and 6 months at deltoid region of arm. |
| Precaution | Syncope may occur |
| Note | This is a recombinant quadrivalent human papillomavirus vaccine , HPV 6, 11, 16 and 18,. It is indicated for prevention of cervical cancer, condyloma acuminata,(genital warts), cervical adenocarcinama in situ, cervical intraepithelial neoplasia grade 2 and 3, vulvar intraepithelial neoplasia grade 2 and 3 , and vulvar intraepithelial neoplasia grade 2 and 3 |